Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Neuropathologica
Published in: Acta Neuropathologica 6/2004

01-06-2004 | Regular Paper

Occurrence of α-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex

Authors: Joseph Sebeo, Patrick R. Hof, Daniel P. Perl

Published in: Acta Neuropathologica | Issue 6/2004

Login to get access

Abstract

Amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC) is a progressive neurodegenerative disease affecting the indigenous Chamorro population of Guam. Neuropathologically, PDC is characterized by neuronal loss in the substantia nigra pars compacta with severe widespread neurofibrillary tangles (NFTs) similar to those observed in Alzheimer’s disease (AD), and is thus considered a tauopathy. Following reports of α-synuclein pathology in PDC patients of Guam, PDC has also been neuropathologically classified as a synucleinopathy. Recently, the presence of α-synuclein-positive bodies has been reported in the cerebellum of some patients with Parkinson’s disease (PD), diffuse Lewy body disease (DLBD), or multiple system atrophy (MSA). Using immunohistochemical techniques, we investigated the deposition of α-synuclein in the cerebellum of Guamanian PDC patients. Numerous α-synuclein-immunoreactive spherical structures were found in the molecular layer of the cerebellum of 63.6% of PDC patients. These structures were only seen in patients showing α-synuclein pathology in the amygdala. The average density of α-synuclein-immunoreactive structures in the cerebellum of Guamanian PDC patients was almost an order of magnitude higher than in non-Guamanian PD patients, and this α-synuclein pathology was much more pronounced in the hemisphere than in the vermis. In addition, double immunohistochemistry revealed that cerebellar α-synuclein is co-localized with the neuronal marker calbindin and with glial-fibrillary acidic protein, suggesting the involvement of Purkinje cells and Bergmann glia. These findings demonstrate that the α-synuclein pathology in PDC of Guam affects not only the amygdala, but also the cerebellum, where it appears to involve both Purkinje cells and specialized astrocytes.
Literature
1.
Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y (2001) Alpha-synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation. Brain Res 888:287–296PubMed
2.
Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Ueda K, Ikeda K, Kawai M (1999) Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson’s disease and in dementia with Lewy bodies. Brain Res 843:53–61PubMed
3.
Buée-Scherrer V, Buée L, Hof PR, Leveugle B, Gilles C, Loerzel AJ, Perl DP, Delacourte A (1995) Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: immunochemical characterization of tau proteins. Am J Pathol 68:924–932
4.
Forman MS, Schmidt ML, Kasturi S, Perl DP, Lee VM, Trojanowski JQ (2002) Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol 160:1725–1731PubMed
5.
Galasko D, Salmon DP, Craig UK, Thal LJ, Schellenberg G, Wiederholt W (2002) Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997–2000. Neurology 58:90–97PubMed
6.
Gentleman SM, Perl D, Allsop D, Clinton J, Royston MC, Roberts GW (1991) Beta (A4)-amyloid protein and parkinsonian dementia complex of Guam. Lancet 337:55–56CrossRef
7.
Grosche J, Matyash V, Moller T, Verkhratsky A, Reichenbach A, Kettenmann H (1999) Microdomains for neuron-glia interaction: parallel fiber signaling to Bergmann glial cells. Nat Neurosci 2:139–143CrossRefPubMed
8.
Hayashi S, Akasaki Y, Morimura Y, Takauchi S, Sato M, Miyoshi K (1992) An autopsy case of late infantile and juvenile neuroaxonal dystrophy with diffuse Lewy bodies and neurofibrillary tangles. Clin Neuropathol 11:1–5PubMed
9.
Hirano A, Malamud N, Kurland LT (1961) Parkinsonism-dementia complex, an endemic disease on the island of Guam II. Pathological features. Brain 84:662–679
10.
Hirano A, Malamud N, Elizan TS, Kurland LT (1966) Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam. Further pathologic studies. Arch Neurol 15:35–51PubMed
11.
Hirano A, Arumugasamy N, Zimmerman HM (1967) Amyotrophic lateral sclerosis. A comparison of Guam and classical cases. Arch Neurol 16:357–363PubMed
12.
Hof PR, Perl DP, Loerzel AJ, Morrison JH (1991) Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer’s disease. Brain Res 564:306–313CrossRefPubMed
13.
Iseki E, Marui W, Kosaka K, Ueda K (1999) Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 265:9–12PubMed
14.
Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, deSilva HA, Kittel A, Saitoh T (1995) The precursor protein of non-A beta component of Alzheimer’s disease is a presynaptic protein of the central nervous system. Neuron 14:467–475PubMed
15.
Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, Jakes R (1999) Alpha-synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 274:25481–25489CrossRefPubMed
16.
Kuzuhara S, Yoshimura M (1993) Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Adv Neurol 60:464–469PubMed
17.
Lilienfeld DE, Perl DP, Olanow CW (1994) Guam neurodegeneration. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 895–908
18.
Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, O’Connell B, Pollen DA, St George-Hyslop P, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ (1998) Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365–1370PubMed
19.
Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ (1999) Antibodies to alpha-synuclein detect Lewy bodies in many Down’s syndrome brains with Alzheimer’s disease. Ann Neurol 45:353–357PubMed
20.
Malamud N, Hirano A, Kurland LT (1961) Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Neurology 5:401–414
21.
Marui W, Iseki E, Ueda K, Kosaka K (2000) Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer’s disease. J Neurol Sci 174:81–84PubMed
22.
Mawal-Dewan M, Schmidt L, Balin B, Perl DP, Lee VMY, Trojanowski JQ (1996) Identification of phosphorylation sites in PHF-tau from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. J Neuropathol Exp Neurol 55:1051–1059
23.
Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T, Takahashi H, Wakabayashi K (2003) α-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol 62:812–819PubMed
24.
Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG (1994) Glutamate-mediated astrocyte-neuron signalling. Nature 369:744–747PubMed
25.
Perl DP (2001) Amyotrophic lateral sclerosis/parkinsonism dementia complex of Guam. In: Hof PR, Mobbs CV (eds) Functional neurobiology of aging. Academic Press, San Diego, pp 183–201
26.
Piao YS, Wakabayashi K, Hayashi S, Yoshimoto M, Takahashi H (2000) Aggregation of α-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients. Clin Neuropathol 19:163–169PubMed
27.
Piao YS, Mori F, Hayashi S, Tanji K, Yoshimoto M, Kakita A, Wakabayashi K, Takahashi H (2003) α-Synuclein pathology affecting Bergmann glia of the cerebellum in patients with α-synucleinopathies. Acta Neuropathol (Berl) 105:403–409
28.
Rezaie P, Cairns NJ, Chadwick A, Lantos PL (1996) Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 212:111–114PubMed
29.
Saito Y, Kawai M, Inoue K, Sasaki R, Arai H, Nanba E, Kuzuhara S, Ihara Y, Kanazawa I, Murayama S (2000) Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course. J Neurol Sci 177:48–59PubMed
30.
Schmidt ML, Martin JA, Lee VM, Trojanowski JQ (1996) Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders. Acta Neuropathol (Berl) 91:475–481
31.
Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha synuclein in Lewy bodies. Nature 388:232–233CrossRefPubMed
32.
Ventura R, Harris KM (1999) Three-dimensional relationships between hippocampal synapses and astrocytes. J Neurosci 19:6897–6906PubMed
33.
Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains. Acta Neuropathol (Berl) 99:14–20
34.
Yamazaki M, Arai Y, Baba M, Iwatsubo T, Mori O, Katayama Y, Oyanagi K (2000) Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol 59:585–591PubMed
Metadata
Title
Occurrence of α-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex
Authors
Joseph Sebeo
Patrick R. Hof
Daniel P. Perl
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 6/2004
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-004-0840-4

Other articles of this Issue 6/2004

Acta Neuropathologica 6/2004 Go to the issue

Regular Paper

Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo

Regular Paper

Pathological properties of the Parkinson’s disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick’s disease

Regular Paper

Evaluation of rapid tests for the diagnosis of transmissible spongiform encephalopathies in sheep and goats

Letter to the Editor

Reply to Lorenz et al.: Osteoprotegerin in the central nervous system

Regular Paper

Topographical and cytopathological lesion analysis of the white matter in Binswanger’s disease brains

Regular Paper

Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions